# Intellia (NTLA) — Earnings

NTLA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ntla/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.80 |
| EPS estimate | −$0.80 |
| EPS surprise | −0.09% |
| Revenue surprise | −40.99% |
| Revenue | $7.7M |
| Revenue estimate | $13.0M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1652130/000119312526337952/ntla-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/82735ee7-a8d8-84ca-8828-4fb7a43f552c.html) |

Intellia reported Q2 2026 results on August 6, 2026. The company posted a loss of $0.80 per share, matching the $0.80 estimate. Revenue was $7.7 million, about 41% below the $13.0 million consensus. Compared with Q2 2025, the loss narrowed from $0.98 per share, while revenue fell about 46% from $14.2 million.

Intellia lost money in every quarter in the table, but the losses have been shrinking. Annual losses were $3.76 per share in 2021, $6.18 in 2022, $5.41 in 2023 and $5.25 in 2024. The deepest quarterly loss was $1.96 in Q1 2022, and Q2 2026's $0.80 is the smallest since early 2021. Revenue is small and uneven, peaking at $28.9 million in Q1 2024. The table has gaps: it has no rows for Q3 2025 or Q1 2026, and no revenue for Q4 2023, so no full-year total can be given for 2025. Intellia beat the EPS estimate in eight of the 20 quarters shown.

Intellia reported Q3 results between November 3 and November 9 in each year from 2021 to 2024. That points to early November 2026 for the next report. It will show whether the narrowing of losses continues.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.80 | −$0.80 | -0.09% | $13.0M | $7.7M |
| Q4 2025 | Feb 26, 2026 | −$0.94 | −$0.83 | 11.81% | $14.4M | $23.0M |
| Q2 2025 | Aug 7, 2025 | −$1.02 | −$0.98 | 3.70% | $11.9M | $14.2M |
| Q1 2025 | May 8, 2025 | −$1.28 | −$1.10 | 14.00% | $12.8M | $16.6M |
| Q4 2024 | Feb 27, 2025 | −$1.33 | −$1.27 | 4.56% | $8.6M | $12.9M |
| Q3 2024 | Nov 7, 2024 | −$1.39 | −$1.34 | 3.60% | $8.3M | $9.1M |
| Q2 2024 | Aug 8, 2024 | −$1.22 | −$1.52 | -24.92% | $19.7M | $7.0M |
| Q1 2024 | May 9, 2024 | −$1.37 | −$1.12 | 18.02% | $11.2M | $28.9M |
| Q4 2023 | Feb 22, 2024 | −$1.44 | −$1.46 | -1.49% | $12.7M | — |
| Q3 2023 | Nov 9, 2023 | −$1.50 | −$1.38 | 7.91% | $13.0M | $12.0M |
| Q2 2023 | Aug 3, 2023 | −$1.32 | −$1.40 | -5.99% | $12.1M | $13.6M |
| Q1 2023 | May 4, 2023 | −$1.40 | −$1.17 | 16.40% | $11.8M | $12.6M |
| Q4 2022 | Feb 23, 2023 | −$1.38 | −$1.40 | -1.54% | $11.3M | $13.6M |
| Q3 2022 | Nov 3, 2022 | −$1.29 | −$1.49 | -15.92% | $11.9M | $13.3M |
| Q2 2022 | Aug 4, 2022 | −$1.30 | −$1.33 | -2.00% | $9.4M | $14.0M |
| Q1 2022 | May 5, 2022 | −$1.11 | −$1.96 | -76.74% | $8.5M | $11.3M |
| Q4 2021 | Feb 24, 2022 | −$0.95 | −$1.09 | -14.86% | $8.3M | $12.9M |
| Q3 2021 | Nov 4, 2021 | −$0.85 | −$0.97 | -14.51% | $8.7M | $7.2M |
| Q2 2021 | Aug 5, 2021 | −$0.63 | −$1.01 | -59.26% | $12.2M | $6.5M |
| Q1 2021 | May 6, 2021 | −$0.66 | −$0.69 | -4.88% | $9.9M | $6.4M |

## Frequently Asked Questions

### When did Intellia (NTLA) last report earnings?

Intellia last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did NTLA beat earnings estimates?

No. Intellia reported EPS of −$0.80 for Q2 2026 against a −$0.80 estimate — a 0.09% miss.

### How much revenue did NTLA report last quarter?

Intellia reported $7.7M in revenue for Q2 2026, against a consensus estimate of $13.0M.

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock
- [EDIT](https://www.lighthorse.io/tickers/edit) — Editas Medicine, Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
